1. Chronic kidney disease in the pathogenesis of acute ischemic stroke
   Bharath Chelluboina et al, 2019, Journal of Cerebral Blood Flow & Metabolism CrossRef
2. HMGB1 facilitates hypoxia‐induced vWF upregulation through TLR2‐MYD88‐SP1 pathway
   Bandana Singh et al, 2016, European Journal of Immunology CrossRef
3. Atrial Fibrillation and Thromboembolism in Patients With Chronic Kidney Disease
   Yee C. Lau et al, 2016, Journal of the American College of Cardiology CrossRef
4. Simvastatin Increases ADAMTS13 Expression in Podocytes
   Lei Shen et al, 2013, Thrombosis Research CrossRef
5. Venous thromboembolism, factor VIII and chronic kidney disease
   Katharine L. Cheung et al, 2018, Thrombosis Research CrossRef
6. ADAMTS13: The von Willebrand Factor Cleaving Protease and Its Role in Thrombotic Thrombocytopenic Purpura
   Surbhi Saini et al, 2013, Proteases in Health and Disease CrossRef
7. Peripheral venous congestion causes inflammation, neurohormonal, and endothelial cell activation
   P. C. Colombo et al, 2014, European Heart Journal CrossRef
8. Low-Dose Aspirin for Prevention of Cardiovascular Disease in Patients with Chronic Kidney Disease
   Ae Jin Kim et al, 2014, PLoS ONE CrossRef
9. Increased levels of circulating (TNF-α) is associated with (-308G/A) promoter polymorphism of TNF-α gene in Diabetic Nephropathy
   Dhamodharan Umapathy et al, 2018, International Journal of Biological Macromolecules CrossRef
10. Vitamin D modulates tissue factor and protease‐activated receptor 2 expression in vascular smooth muscle cells
    Julio M. Martinez‐Moreno et al, 2016, The FASEB Journal CrossRef
11. von Willebrand Factor, ADAMTS13 Activity, and Decline in Kidney Function: A Population-Based Cohort Study
    Sanaz Sedaghat et al, 2016, American Journal of Kidney Diseases CrossRef
12. Peptidomics of Body Fluids
    Prathibha Reddy et al, 2018, Integration of Omics Approaches and Systems Biology for Clinical Applications CrossRef
13. Proteinuria, but Not eGFR, Predicts Stroke Risk in Chronic Kidney Disease
    Danielle K. Sandsmark et al, 2015, Stroke CrossRef
14. Cadmium regulates von Willebrand factor and occludin expression in glomerular endothelial cells of mice in a TNF-α-dependent manner
    Zongguo Sun et al, 2019, Renal Failure CrossRef
15. Urinary proteomics and molecular determinants of chronic kidney disease: possible link to proteases
    Szymon Filip et al, 2014, Expert Review of Proteomics CrossRef
16. Secretion of von Willebrand factor by endothelial cells links sodium to hypercoagulability and thrombosis
    Natalia I. Dmitrieva et al, 2014, Proceedings of the National Academy of Sciences CrossRef
17. Soluble Urokinase Receptors in Focal Segmental Glomerulosclerosis: A Review on the Scientific Point of View
    Andreas Kronbichler et al, 2016, Journal of Immunology Research CrossRef
18. Association between ADAMTS13 deficiency and cardiovascular events in chronic hemodialysis patients
    Shih-Yuan Hung et al, 2021, Scientific Reports CrossRef
19. Blocking Von Willebrand Factor for Treatment of Cutaneous Inflammation
    Carina Hillgruber et al, 2014, Journal of Investigative Dermatology CrossRef
20. Different impact of aspirin on renal progression in patients with predialysis advanced chronic kidney disease with or without previous stroke
    Kuang-Chih Hsiao et al, 2017, European Journal of Internal Medicine CrossRef
21. Circulating active von Willebrand factor levels are increased in chronic kidney disease and end-stage renal disease
    Lisa N van der Vorm et al, 2020, Clinical Kidney Journal CrossRef